DOD Biotech Ownership
| DOD Stock | 1.28 0.03 2.40% |
DOD |
DOD Stock Ownership Analysis
About 48.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. DOD Biotech Public last dividend was issued on the 13th of March 2020. To learn more about DOD Biotech Public call Thanin Srisethi at 66 3 444 6333 or check out https://www.dodbiotech.com.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in DOD Stock
DOD Biotech financial ratios help investors to determine whether DOD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOD with respect to the benefits of owning DOD Biotech security.